Recently, Schisandrin B, the main bioactive ingredient of the Chinese herb “Schisandra chinensis”, was reported to improve liver fibrosis in the CCl4 mouse model by regulating Nrf2 and TGF-β/SMAD signaling pathways [159]. This evidence concerns the gene NFE2L2 and Hepatic fibrosis.